Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia

Detalles Bibliográficos
Autores principales: Li, Quanfu, Jin, Gaowa, Jiang, Caihong, Zhang, Zewei, Hou, Jixiang, Zhao, Juan, Chen, Feng, Li, Zhenhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425230/
https://www.ncbi.nlm.nih.gov/pubmed/34522277
http://dx.doi.org/10.5114/aoms/141134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425230/
https://www.ncbi.nlm.nih.gov/pubmed/34522277
http://dx.doi.org/10.5114/aoms/141134

Ejemplares similares